[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 201 Introduced in Senate (IS)]
<DOC>
119th CONGRESS
1st Session
S. 201
To provide for a study by the National Academies of Sciences,
Engineering, and Medicine on the prevalence and mortality of cancer
among individuals who served as active duty aircrew in the Armed
Forces, and for other purposes.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
January 23, 2025
Mr. Kelly (for himself and Mr. Cotton) introduced the following bill;
which was read twice and referred to the Committee on Veterans' Affairs
_______________________________________________________________________
A BILL
To provide for a study by the National Academies of Sciences,
Engineering, and Medicine on the prevalence and mortality of cancer
among individuals who served as active duty aircrew in the Armed
Forces, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``ACES Act''.
SEC. 2. NATIONAL ACADEMIES STUDY ON PREVALENCE AND MORTALITY OF CANCER
AMONG INDIVIDUALS WHO SERVED AS ACTIVE DUTY AIRCREW IN
THE ARMED FORCES.
(a) In General.--The Secretary of Veterans Affairs shall enter into
an agreement with the National Academies of Sciences, Engineering, and
Medicine (in this section referred to as the ``National Academies''),
under which the National Academies shall conduct a study on the
prevalence and mortality of cancers among covered individuals.
(b) Study.--The study required under subsection (a) shall--
(1) identify exposures associated with military occupations
of covered individuals, including relating to chemicals,
compounds, agents, and other phenomena;
(2) review the literature to determine associations between
exposures referred to in paragraph (1) and the incidence or
prevalence of overall cancer morbidity, overall cancer
mortality, and increased incidence or prevalence of--
(A) brain cancer;
(B) colon and rectal cancers;
(C) kidney cancer;
(D) lung cancer;
(E) melanoma skin cancer;
(F) non-Hodgkin lymphoma;
(G) pancreatic cancer;
(H) prostate cancer;
(I) testicular cancer;
(J) thyroid cancer;
(K) urinary bladder cancer; and
(L) other cancers as determined appropriate by the
Secretary of Veterans Affairs, in consultation with the
National Academies; and
(3) determine, to the extent possible, the prevalence of
and mortality from the cancers specified in paragraph (2) among
covered individuals by using available sources of data, which
may include--
(A) health care and other administrative databases
of the Department of Veterans Affairs, the Department
of Defense, and the individual Services, respectively;
(B) the national death index maintained by the
National Center for Health Statistics of the Centers
for Disease Control and Prevention; and
(C) the study conducted under section 750 of the
William M. (Mac) Thornberry National Defense
Authorization Act for Fiscal Year 2021 (Public Law 116-
283; 134 Stat. 3716).
(c) Report.--At the conclusion of the study required under
subsection (a), the National Academies shall submit to the Secretary
and to the Committee on Veterans' Affairs of the Senate and the
Committee on Veterans' Affairs of the House of Representatives a report
containing the results of the study described in subsection (b).
(d) Covered Individual Defined.--In this section, the term
``covered individual'' means an individual who served on active duty in
the Army, Navy, Air Force, or Marine Corps as an aircrew member of a
fixed-wing aircraft, including as a pilot, navigator, weapons systems
operator, aircraft system operator, or any other crew member who
regularly flew in a fixed-wing aircraft.
<all>